menu toggle

Podcast: Industry led product development in a rapidly changing CGT landscape

By AmerisourceBergen

In Episode 2 of TrakCel’s Tracking Cells Podcast, Imran Ahmed, Head of Product at TrakCel, chats with Dale Hanna, Director, Cell and Gene Therapy Solutions at AmerisourceBergen, about the essential aspects of product development and its impact of CGTs. 
CGT landscape
Emphasizing the importance of understanding patient needs and creating seamless user experience to improve patient access and overall outcomes, they cover a broad range of topics including agility, resource crunch in the CGT supply chain, and the role of new technologies.

Learn more about our end to end suite of commercialization solutions for biopharma companies

Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers.
Topics:
Cell and gene therapy Commercialization Innovation

Related Content

Manufacturers

In conversation with TrakCel: Why successful partnerships can help accelerate advanced therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Accelerating advanced therapies

Manufacturers

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

A photo of David Senior wearing a dark gray suit, white collared shirt, and dark blue tie with a diamond pattern
David Senior
AmerisourceBergen
October 2022
Reimbursement models for CGT

Manufacturers

Alternate payer engagement models are changing the landscape

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2022
Cell and gene therapy Alternate payer engagement models